CompoAtlas

Activis Degluco

Natural health product licensed in Canada

Licence holder
Nutragenius Inc.
NPN or DIN-HM
80083268
Status
Inactive licence
Licence date
19 February 2018
Revision date
Not provided
Form
Capsule
Route of administration
Orale
Application type
Non traditionnelle

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Panax quinquefolius

Source : Racine

Extraction ratio : 10:1

Dry plant equivalent : 500 mg

50 mgNot calculated
Propolis

Source : Apis mellifera - sécrétion

20 mgNot calculated
Glucomannane

Source : Amorphophallus konjac - tubercule

200 mgNot calculated
bêta-glucane

Source : Avena sativa- Graine

40 mgNot calculated
Vaccinium angustifolium

Source : Fruit

Extraction ratio : 20:1

Dry plant equivalent : 400 mg

20 mgNot calculated
Vitamine C

Source : Ascorbate de calcium

20 mg120,000 µg
Acide DL-alpha lipoÏque

Source : Acide DL-alpha-lipoÏque

60 mgNot calculated
L-carnitine

Source : L-tartrate de carnitine

30 mgNot calculated
Gymnema sylvestre

Source : Feuille

Potency : 25 % Gymnemic acids

50 mgNot calculated
Morus alba

Source : Feuille

Extraction ratio : 10:1

Dry plant equivalent : 250 mg

25 mgNot calculated

Non-medicinal ingredients

Chlorophylle, Hypromellose

PopulationAgeQuantity per servingFrequency
AdultesNot specified2 Capsule3 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

Used in Herbal Medicine as supportive therapy for the promotion of healthy glucose levels. Source of antioxidants that help protect cell against cell damage caused by free radicals.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80083268

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line